Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells

Stem Cell Research

Volumn 14, Issue 1, 2015, Pages 95-104

  Ito, Sawa ^a   Barrett, A John ^a   Dutra, Amalia ^b   Pak, Evgenia ^b   Miner, Samantha ^a   Keyvanfar, Keyvan ^a   Hensel, Nancy F ^a   Rezvani, Katayoun ^c   Muranski, Pawel ^a   Liu, Paul ^b   Melenhorst, J Joseph ^a,d   Larochelle, Andre ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; ANTINEOPLASTIC ANTIMETABOLITE; CYTARABINE; INTERLEUKIN 3; STEM CELL FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW STROMA CELL; CANCER STEM CELL; CELL CONTACT; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL LINEAGE; CELL SURFACE; CELL SURVIVAL; CELL VIABILITY; CHEMOSENSITIVITY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; KARYOTYPE; MALE; MESENCHYMAL STROMA CELL; MOUSE; MYELOID LEUKEMIA CELL LINE; NONHUMAN; PHENOTYPE; ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL; APOPTOSIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; IMMUNOPHENOTYPING; KARYOTYPING; KNOCKOUT MOUSE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; TRANSPLANTATION;

MUS;

ANIMALS; ANTIGENS, CD34; ANTIGENS, CD38; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTARABINE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-3; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, KNOCKOUT; NEOPLASTIC STEM CELLS; STEM CELL FACTOR;

EID: 84920063456     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.11.007     Document Type: Article

References (17)

1. Bhatia M., Bonnet D., Murdoch B., Gan O.I., Dick J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat. Med. 1998, 4:1038-1045.
2. de Lima M., McNiece I., Robinson S.N., Munsell M., Eapen M., Horowitz M., Alousi A., Saliba R., McMannis J.D., Kaur I., Kebriaei P., Parmar S., Popat U., Hosing C., Champlin R., Bollard C., Molldrem J.J., Jones R.B., Nieto Y., Andersson B.S., Shah N., Oran B., Cooper L.J., Worth L., Qazilbash M.H., Korbling M., Rondon G., Ciurea S., Bosque D., Maewal I., Simmons P.J., Shpall E.J. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N. Engl. J. Med. 2012, 367:2305-2315.
3. Dick J.E. Stem cell concepts renew cancer research. Blood 2008, 112:4793-4807.
4. Eppert K., Takenaka K., Lechman E.R., Waldron L., Nilsson B., van Galen P., Metzeler K.H., Poeppl A., Ling V., Beyene J., Canty A.J., Danska J.S., Bohlander S.K., Buske C., Minden M.D., Golub T.R., Jurisica I., Ebert B.L., Dick J.E. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 2011, 17:1086-1093.
5. Gentles A.J., Plevritis S.K., Majeti R., Alizadeh A.A. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 2010, 304:2706-2715.
6. Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell 2012, 10:709-716.
7. Kennedy J.A., Barabe F. Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia. Leukemia 2008, 22:2029-2040.
8. Klco J.M., Spencer D.H., Lamprecht T.L., Sarkaria S.M., Wylie T., Magrini V., Hundal J., Walker J., Varghese N., Erdmann-Gilmore P., Lichti C.F., Meyer M.R., Townsend R.R., Wilson R.K., Mardis E.R., Ley T.J. Genomic impact of transient low-dose decitabine treatment on primary AML cells. Blood 2013, 121:1633-1643.
9. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
10. Misaghian N., Ligresti G., Steelman L.S., Bertrand F.E., Basecke J., Libra M., Nicoletti F., Stivala F., Milella M., Tafuri A., Cervello M., Martelli A.M., McCubrey J.A. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia 2009, 23:25-42.
11. Robinson S.N., Ng J., Niu T., Yang H., McMannis J.D., Karandish S., Kaur I., Fu P., Del Angel M., Messinger R., Flagge F., de Lima M., Decker W., Xing D., Champlin R., Shpall E.J. Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant. 2006, 37:359-366.
12. Saito Y., Kitamura H., Hijikata A., Tomizawa-Murasawa M., Tanaka S., Takagi S., Uchida N., Suzuki N., Sone A., Najima Y., Ozawa H., Wake A., Taniguchi S., Shultz L.D., Ohara O., Ishikawa F. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci. Transl. Med. 2010, 2:17ra19.
13. Saito Y., Yuki H., Kuratani M., Hashizume Y., Takagi S., Honma T., Tanaka A., Shirouzu M., Mikuni J., Handa N., Ogahara I., Sone A., Najima Y., Tomabechi Y., Wakiyama M., Uchida N., Tomizawa-Murasawa M., Kaneko A., Tanaka S., Suzuki N., Kajita H., Aoki Y., Ohara O., Shultz L.D., Fukami T., Goto T., Taniguchi S., Yokoyama S., Ishikawa F. A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo. Sci. Transl. Med. 2013, 5. (181ra152).
14. Sarry J.E., Murphy K., Perry R., Sanchez P.V., Secreto A., Keefer C., Swider C.R., Strzelecki A.C., Cavelier C., Recher C., Mansat-De Mas V., Delabesse E., Danet-Desnoyers G., Carroll M. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rgammac-deficient mice. J. Clin. Invest. 2011, 121:384-395.
15. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., Ried T. Multicolor spectral karyotyping of human chromosomes. Science 1996, 273:494-497.
16. International Standing Committee on Human Cytogenetic Nomenclature, Shaffer L.G., Slovak M.L., Campbell L.J. ISCN 2009: An International System for Human Cytogenetic Nomenclature (2009) 2009, Karger, Basel.
17. van Gosliga D., Schepers H., Rizo A., van der Kolk D., Vellenga E., Schuringa J.J. Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells. Exp. Hematol. 2007, 35:1538-1549.